产前抗抑郁药使用与不良新生儿结局风险
基于OptumLabs数据库226 932例单胎分娩的纵向聚类分析,将产前抗抑郁药使用分为5种轨迹,发现中高持续剂量与早产风险增加相关,所有4种用药轨迹均以剂量-反应方式增加新生儿呼吸窘迫风险。
要点
- 中持续(约40mg/天)和高持续(约75mg/天)用药轨迹与早产风险增加相关。
- 所有4种用药轨迹均以剂量-反应方式增加新生儿呼吸窘迫风险。
- 中持续用药与重大心脏畸形风险增加相关,但与抑郁或焦虑参照组比较时结果包含无效值。
核心结论
- 研究结果支持继续使用最低有效剂量治疗抑郁或焦虑以利于母亲,但同时提示所有用药组新生儿呼吸窘迫风险增加,中高持续剂量组早产风险增加。
研究设计与样本
- 基于OptumLabs Data Warehouse的226 932例单胎分娩的回顾性队列研究,采用纵向聚类分析将抗抑郁药使用转化为氟西汀等效剂量并分组。
主要发现
- 从15 041例(6.6%)孕期暴露于抗抑郁药的妊娠中识别出5种用药轨迹:低使用(约10mg/天)伴孕早期减量、低持续使用(约20mg/天)、中等使用(约40mg/天)伴孕早期减量、中等持续使用(约40mg/天)、高持续使用(约75mg/天)。
- 中等持续使用增加重大心脏畸形风险,但与抑郁或焦虑参照组比较时结果包含无效值。
- 中等持续使用(调整RR 1.31;95%CI 1.16-1.49)和高持续使用(调整RR 1.78;95%CI 1.48-2.14)轨迹与早产风险增加相关。
- 所有4种轨迹均以剂量-反应方式增加新生儿呼吸窘迫风险(调整RR从1.36[95%CI 1.20-1.50]到2.23[95%CI 1.83-2.77])。
关键数值与推荐
- 结局发生率:重大心脏畸形11.7/1000例出生,早产75.7/1000例出生,新生儿呼吸窘迫54.2/1000例出生。
- 以最低轨迹为主要参照组,以无抗抑郁药处方的抑郁和焦虑为次要参照组。
临床怎么用
- 临床决策时应权衡母亲抑郁或焦虑治疗获益与新生儿呼吸窘迫及早产风险,倾向于使用最低有效剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To estimate the risk of neonatal outcomes from patterns of prenatal antidepressant use. METHODS: From the OptumLabs Data Warehouse, 226 932 singleton deliveries were identified. Antidepressant claims with coverage between the last menstrual period and 35 weeks' gestation were converted to fluoxetine equivalents, and a longitudinal cluster analysis was performed. Outcomes included major cardiac malformations (11.7 of 1000 births), preterm birth (75.7 of 1000 births), and newborn respiratory distress (54.2 of 1000 births). The lowest trajectory was the primary reference group, and depression and anxiety with no antidepressant claims served as secondary reference groups. RESULTS: From 15 041 (6.6%) pregnancies exposed to an antidepressant, use patterns were best described as (1) low use (∼10 mg/day) with first-trimester reduction, (2) low sustained use (∼20 mg/day), (3) moderate use (∼40 mg/day) with first-trimester reduction, (4) moderate sustained use (∼40 mg/day), and (5) high sustained use (∼75 mg/day). Moderate sustained use increased the risk of major cardiac malformations, although results included the null when compared with depression or anxiety reference groups. Moderate sustained (adjusted risk ratio [RR] 1.31; 95% confidence interval [CI] 1.16-1.49) and high sustained (adjusted RR 1.78; 95% CI 1.48-2.14) trajectories were associated with an increased risk of preterm birth. All 4 trajectories increased the risk of neonatal respiratory distress in a dose-response fashion (adjusted RRs 1.36 [95% CI 1.20-1.50] to 2.23 [95% CI 1.83-2.77]). CONCLUSIONS: Although findings support continuation of the lowest effective dose to treat depression or anxiety, which benefits the mother, they also highlight an increased risk for newborn respiratory distress in all groups and preterm birth at moderate to high sustained doses.
引用
- Bandoli G, Chambers CD, Wells A, et al. Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes. Pediatrics. 2020. PMID: 32513841. doi:10.1542/peds.2019-2493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。